Obesity or Overweight Clinical Trials

5 recruiting

Obesity or Overweight Trials at a Glance

7 actively recruiting trials for obesity or overweight are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Phase 3 with 5 trials, with the heaviest enrollment activity in Louisville, Aguascalientes, and Aichi. Lead sponsors running obesity or overweight studies include Eli Lilly and Company, Hoffmann-La Roche, and Gan & Lee Pharmaceuticals..

Browse obesity or overweight trials by phase

Treatments under study

About Obesity or Overweight Clinical Trials

Looking for clinical trials for Obesity or Overweight? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Obesity or Overweight trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Obesity or Overweight clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Obesity or OverweightType 2 Diabetes Mellitus
Hoffmann-La Roche1,600 enrolled36 locationsNCT07351058
Recruiting
Phase 3

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Obesity or Overweight
Hoffmann-La Roche2,000 enrolled28 locationsNCT07351045
Recruiting
Phase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ulcerative ColitisObesity or Overweight
Eli Lilly and Company350 enrolled191 locationsNCT06937086
Recruiting
Phase 3

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's DiseaseObesity or Overweight
Eli Lilly and Company290 enrolled187 locationsNCT06937099
Recruiting
Phase 3

A Study of IBI362 in Chinese Adolescents With Obesity or Overweight

Adolescents With Obesity or Overweight With Weight-Related Comorbidities
Innovent Biologics (Suzhou) Co. Ltd.180 enrolled1 locationNCT07255209
Recruiting
Phase 1

Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection

Obesity or Overweight
Gan & Lee Pharmaceuticals.60 enrolled1 locationNCT07128888
Recruiting
Phase 1

Phase I Study of XTL6001 Injection in Healthy and Obese Subjects

Weight Management in Adult Patients With Obesity or Overweight
Shanghai Xitaili Biomedicine Technology co., Ltd.80 enrolled1 locationNCT07205432